An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...
Aspirin’s mechanism of action (IMAGE) American Society for Biochemistry and Molecular Biology Caption Researchers have made new discoveries about aspirin’s mechanism of action and cellular targets.
Researchers warn that this finding does not imply that cancer patients can take aspirin without a medical prescription.
The INSPIRES, a double-blind, placebo-controlled trial, involved patients with mild ischemic stroke or high-risk TIA of presumed atherosclerotic cause who had not undergone thrombolysis or ...
People at risk of a cardiac event after a percutaneous coronary intervention (PCI) stent procedure who received long-term antiplatelet therapy with clopidogrel were 29% less likely to die than those ...
Dual antiplatelet therapy (DAPT) was not more effective than aspirin alone for the prevention of major adverse cardiovascular events and increased major bleeding in patients with acute coronary ...
Hosted on MSN
Dual antiplatelet therapy after heart bypass surgery offers no added benefit over aspirin alone
Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone - and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at ...
People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results